| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |